Due to a national shortage of blood collection tubes, you may experience upwards of a 2-hour delay in processing time for certain tests. Someone from our team will advise you if your scheduled lab test is affected by this delay. We thank you in advance for your patience.

Clinical Trials & Research

PH3 Ven+G vs FCR/BR in Fit untreated CLL

A PROSPECTIVE, OPEN-LABEL, MULTICENTER RANDOMIZED PHASE III TRIAL TO COMPARE THE EFFICACY AND SAFETY OF A COMBINED REGIMEN OF OBINUTUZUMAB AND VENETOCLAX VERSUS FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR)/ BENDAMUSTINE AND RITUXIMAB (BR) IN FIT PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITHOUT DEL (17P) OR TP53 MUTATION (CO41685)

Disease Types: Leukemia,&nbs

Available at: {clinical_trial_location backspace="7"}PH3 Ven+G vs FCR/BR in Fit untreated CLL, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}